Position in ALLO
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$490,505
+$212,387 QoQ
Shares Held
201,027
-1.0% QoQ
Ownership
0.058%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 20%
Shared 0%
None 80%
Common Shares in ALLO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,238,289,073 across 287 Biotechnology names. ALLO ranks #158 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,140 | $188,948,935 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,781 | $121,907,911 | |
| 3 | INCY |
Incyte Corp
|
693,665 | $65,287,749 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,277 | $64,611,300 | |
| 5 | INSM |
INSMED Inc
|
272,615 | $44,578,004 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
164,542 | $31,106,665 | |
| 7 | EXEL |
Exelixis, Inc.
|
723,931 | $31,049,400 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,113,266 | $30,837,468 |
All Filings in ALLO
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $490,505 | 201,027 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $278,118 | 203,006 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $261,300 | 210,726 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $236,549 | 209,336 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $268,213 | 183,708 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $408,350 | 191,714 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $487,723 | 174,187 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $383,303 | 164,508 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $679,596 | 152,035 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $468,534 | 145,961 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $441,089 | 139,145 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $716,877 | 144,241 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $638,406 | 129,232 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $789,407 | 125,502 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,391,828 | 128,873 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,353,168 | 118,699 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $769,047 | 84,418 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,341,621 | 89,921 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,332,737 | 90,768 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,290,606 | 87,830 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $2,166,078 | 61,362 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $1,701,075 | 67,396 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,419,624 | 64,164 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $3,253,891 | 75,990 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,061,112 | 54,584 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||